ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 708854 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 708854; 2) Community: the network communities that were significantly associated with the response to NSC 708854; 3) Molecule: the relationships between components within communities and NSC 708854; 4) MDR: the compounds that were significantly associated with the NSC 708854.

NSC Compound Enrichment Correlation
NSC 705840 Null 0.00578566967432527 0.36959827
NSC 718781 Erlotinib hydrochloride 0.00640068043275774 -0.41219985
NSC 726089 11-(4-dimethylaminobenzyliden)-8-methoxy-5-methyl-11H-indolo [1,2-b]indazolium trifluoromethanesulfonate 0.00640068043275774 0.34505417
NSC 744688 Null 0.00640068043275774 0.26302338
NSC 750050 Null 0.00640068043275774 0.34520924
NSC 762908 2-(4-(methylsulfonyl)phenyl)-6-p-tolyl-4,5-dihydropyridazin-3(2H)-one 0.00640068043275774 0.31087934
NSC 143241 Dibenzo[de,g]quinoline-6-carboxylic acid, 4,5-dihydro- 1,2,9,10-tetramethoxy-, ethyl ester 0.00640068043275779 0.3591055
NSC 315626 Butyric acid, rhodium salt (4:2) 0.00640068043275779 0.42780633
NSC 325268 Null 0.00640068043275779 0.2937302
NSC 326408 Rocaglamide (FR AGLAIA ELLIPTIFOLIA) 0.00640068043275779 0.3981697
Total:92  Current:16    [First] [Prev] [Next] [Last]